aluates Reports

$ 0.0

Automative

Canine Arthritis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-28U11968

Global Canine Arthritis Treatment Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Canine Arthritis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28U11968

Report

September 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Elanco (Eli Lilly and Company)

Boehringer Ingelheim

Zoetis Inc

Vetoquinol

Bayer

Aratana Therapeutics Inc

Norbrook Laboratories Limited

VETSTEM BIOPHARMA

Dechra Pharmaceuticals Plc

Canine Arthritis Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Canine Arthritis Treatment - Market

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.

The global market for Canine Arthritis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Canine Arthritis Treatment by region & country, by Type, and by Application.

The Canine Arthritis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Treatment.

Market Segmentation

Scope of Canine Arthritis Treatment - Market Report

Report Metric	Details
Report Name	Canine Arthritis Treatment - Market
CAGR	5%
Segment by Type:	Non-Steroidal Anti-Inflammatory Drugs Opioids
Segment by Application	Veterinary Hospitals and Clinics Drug Stores E-commerce
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Canine Arthritis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Canine Arthritis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Canine Arthritis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Canine Arthritis Treatment - Market report?

Ans: The main players in the Canine Arthritis Treatment - Market are Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc

What are the Application segmentation covered in the Canine Arthritis Treatment - Market report?

Ans: The Applications covered in the Canine Arthritis Treatment - Market report are Veterinary Hospitals and Clinics, Drug Stores, E-commerce

What are the Type segmentation covered in the Canine Arthritis Treatment - Market report?

Ans: The Types covered in the Canine Arthritis Treatment - Market report are Non-Steroidal Anti-Inflammatory Drugs, Opioids

Recommended Reports

Canine Therapeutics

Veterinary Pain Relief

Companion Animal Care

1 Market Overview

1.1 Canine Arthritis Treatment Product Introduction

1.2 Global Canine Arthritis Treatment Market Size Forecast

1.3 Canine Arthritis Treatment Market Trends & Drivers

1.3.1 Canine Arthritis Treatment Industry Trends

1.3.2 Canine Arthritis Treatment Market Drivers & Opportunity

1.3.3 Canine Arthritis Treatment Market Challenges

1.3.4 Canine Arthritis Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Canine Arthritis Treatment Players Revenue Ranking (2023)

2.2 Global Canine Arthritis Treatment Revenue by Company (2019-2024)

2.3 Key Companies Canine Arthritis Treatment Manufacturing Base Distribution and Headquarters

2.4 Key Companies Canine Arthritis Treatment Product Offered

2.5 Key Companies Time to Begin Mass Production of Canine Arthritis Treatment

2.6 Canine Arthritis Treatment Market Competitive Analysis

2.6.1 Canine Arthritis Treatment Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Canine Arthritis Treatment Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Non-Steroidal Anti-Inflammatory Drugs

3.1.2 Opioids

3.2 Global Canine Arthritis Treatment Sales Value by Type

3.2.1 Global Canine Arthritis Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Canine Arthritis Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Canine Arthritis Treatment Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Veterinary Hospitals and Clinics

4.1.2 Drug Stores

4.1.3 E-commerce

4.2 Global Canine Arthritis Treatment Sales Value by Application

4.2.1 Global Canine Arthritis Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Canine Arthritis Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Canine Arthritis Treatment Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Canine Arthritis Treatment Sales Value by Region

5.1.1 Global Canine Arthritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Canine Arthritis Treatment Sales Value by Region (2019-2024)

5.1.3 Global Canine Arthritis Treatment Sales Value by Region (2025-2030)

5.1.4 Global Canine Arthritis Treatment Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Canine Arthritis Treatment Sales Value, 2019-2030

5.2.2 North America Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Canine Arthritis Treatment Sales Value, 2019-2030

5.3.2 Europe Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Canine Arthritis Treatment Sales Value, 2019-2030

5.4.2 Asia Pacific Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Canine Arthritis Treatment Sales Value, 2019-2030

5.5.2 South America Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Canine Arthritis Treatment Sales Value, 2019-2030

5.6.2 Middle East & Africa Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Canine Arthritis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Canine Arthritis Treatment Sales Value

6.3 United States

6.3.1 United States Canine Arthritis Treatment Sales Value, 2019-2030

6.3.2 United States Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Canine Arthritis Treatment Sales Value, 2019-2030

6.4.2 Europe Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Canine Arthritis Treatment Sales Value, 2019-2030

6.5.2 China Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Canine Arthritis Treatment Sales Value, 2019-2030

6.6.2 Japan Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Canine Arthritis Treatment Sales Value, 2019-2030

6.7.2 South Korea Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Canine Arthritis Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Canine Arthritis Treatment Sales Value, 2019-2030

6.9.2 India Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Canine Arthritis Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Elanco (Eli Lilly and Company)

7.1.1 Elanco (Eli Lilly and Company) Profile

7.1.2 Elanco (Eli Lilly and Company) Main Business

7.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Products, Services and Solutions

7.1.4 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.1.5 Elanco (Eli Lilly and Company) Recent Developments

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Profile

7.2.2 Boehringer Ingelheim Main Business

7.2.3 Boehringer Ingelheim Canine Arthritis Treatment Products, Services and Solutions

7.2.4 Boehringer Ingelheim Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.2.5 Boehringer Ingelheim Recent Developments

7.3 Zoetis Inc

7.3.1 Zoetis Inc Profile

7.3.2 Zoetis Inc Main Business

7.3.3 Zoetis Inc Canine Arthritis Treatment Products, Services and Solutions

7.3.4 Zoetis Inc Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.3.5 Vetoquinol S.A. Recent Developments

7.4 Vetoquinol S.A.

7.4.1 Vetoquinol S.A. Profile

7.4.2 Vetoquinol S.A. Main Business

7.4.3 Vetoquinol S.A. Canine Arthritis Treatment Products, Services and Solutions

7.4.4 Vetoquinol S.A. Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.4.5 Vetoquinol S.A. Recent Developments

7.5 Bayer AG

7.5.1 Bayer AG Profile

7.5.2 Bayer AG Main Business

7.5.3 Bayer AG Canine Arthritis Treatment Products, Services and Solutions

7.5.4 Bayer AG Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.5.5 Bayer AG Recent Developments

7.6 Aratana Therapeutics Inc

7.6.1 Aratana Therapeutics Inc Profile

7.6.2 Aratana Therapeutics Inc Main Business

7.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Products, Services and Solutions

7.6.4 Aratana Therapeutics Inc Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.6.5 Aratana Therapeutics Inc Recent Developments

7.7 Norbrook Laboratories Limited

7.7.1 Norbrook Laboratories Limited Profile

7.7.2 Norbrook Laboratories Limited Main Business

7.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Products, Services and Solutions

7.7.4 Norbrook Laboratories Limited Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.7.5 Norbrook Laboratories Limited Recent Developments

7.8 VetStem Biopharma

7.8.1 VetStem Biopharma Profile

7.8.2 VetStem Biopharma Main Business

7.8.3 VetStem Biopharma Canine Arthritis Treatment Products, Services and Solutions

7.8.4 VetStem Biopharma Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.8.5 VetStem Biopharma Recent Developments

7.9 Dechra Pharmaceuticals Plc

7.9.1 Dechra Pharmaceuticals Plc Profile

7.9.2 Dechra Pharmaceuticals Plc Main Business

7.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Products, Services and Solutions

7.9.4 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue (US$ Million) & (2019-2024)

7.9.5 Dechra Pharmaceuticals Plc Recent Developments

8 Industry Chain Analysis

8.1 Canine Arthritis Treatment Industrial Chain

8.2 Canine Arthritis Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Canine Arthritis Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Canine Arthritis Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Elanco (Eli Lilly and Company)

Boehringer Ingelheim

Zoetis Inc

Vetoquinol

Bayer

Aratana Therapeutics Inc

Norbrook Laboratories Limited

VETSTEM BIOPHARMA

Dechra Pharmaceuticals Plc

List of Tables

Table 1. Canine Arthritis Treatment Market Trends

Table 2. Canine Arthritis Treatment Market Drivers & Opportunity

Table 3. Canine Arthritis Treatment Market Challenges

Table 4. Canine Arthritis Treatment Market Restraints

Table 5. Global Canine Arthritis Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Canine Arthritis Treatment Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Canine Arthritis Treatment Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Canine Arthritis Treatment Product Type

Table 9. Key Companies Time to Begin Mass Production of Canine Arthritis Treatment

Table 10. Global Canine Arthritis Treatment Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Canine Arthritis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Canine Arthritis Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Canine Arthritis Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Canine Arthritis Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Canine Arthritis Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Canine Arthritis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Canine Arthritis Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Canine Arthritis Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Canine Arthritis Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Canine Arthritis Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Canine Arthritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Canine Arthritis Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Canine Arthritis Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Canine Arthritis Treatment Sales Value by Region (2019-2024) & (%)

Table 27. Global Canine Arthritis Treatment Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Canine Arthritis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Canine Arthritis Treatment Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Canine Arthritis Treatment Sales Value, (2025-2030) & (US$ Million)

Table 31. Elanco (Eli Lilly and Company) Basic Information List

Table 32. Elanco (Eli Lilly and Company) Description and Business Overview

Table 33. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Products, Services and Solutions

Table 34. Revenue (US$ Million) in Canine Arthritis Treatment Business of Elanco (Eli Lilly and Company) (2019-2024)

Table 35. Elanco (Eli Lilly and Company) Recent Developments

Table 36. Boehringer Ingelheim Basic Information List

Table 37. Boehringer Ingelheim Description and Business Overview

Table 38. Boehringer Ingelheim Canine Arthritis Treatment Products, Services and Solutions

Table 39. Revenue (US$ Million) in Canine Arthritis Treatment Business of Boehringer Ingelheim (2019-2024)

Table 40. Boehringer Ingelheim Recent Developments

Table 41. Zoetis Inc Basic Information List

Table 42. Zoetis Inc Description and Business Overview

Table 43. Zoetis Inc Canine Arthritis Treatment Products, Services and Solutions

Table 44. Revenue (US$ Million) in Canine Arthritis Treatment Business of Zoetis Inc (2019-2024)

Table 45. Zoetis Inc Recent Developments

Table 46. Vetoquinol S.A. Basic Information List

Table 47. Vetoquinol S.A. Description and Business Overview

Table 48. Vetoquinol S.A. Canine Arthritis Treatment Products, Services and Solutions

Table 49. Revenue (US$ Million) in Canine Arthritis Treatment Business of Vetoquinol S.A. (2019-2024)

Table 50. Vetoquinol S.A. Recent Developments

Table 51. Bayer AG Basic Information List

Table 52. Bayer AG Description and Business Overview

Table 53. Bayer AG Canine Arthritis Treatment Products, Services and Solutions

Table 54. Revenue (US$ Million) in Canine Arthritis Treatment Business of Bayer AG (2019-2024)

Table 55. Bayer AG Recent Developments

Table 56. Aratana Therapeutics Inc Basic Information List

Table 57. Aratana Therapeutics Inc Description and Business Overview

Table 58. Aratana Therapeutics Inc Canine Arthritis Treatment Products, Services and Solutions

Table 59. Revenue (US$ Million) in Canine Arthritis Treatment Business of Aratana Therapeutics Inc (2019-2024)

Table 60. Aratana Therapeutics Inc Recent Developments

Table 61. Norbrook Laboratories Limited Basic Information List

Table 62. Norbrook Laboratories Limited Description and Business Overview

Table 63. Norbrook Laboratories Limited Canine Arthritis Treatment Products, Services and Solutions

Table 64. Revenue (US$ Million) in Canine Arthritis Treatment Business of Norbrook Laboratories Limited (2019-2024)

Table 65. Norbrook Laboratories Limited Recent Developments

Table 66. VetStem Biopharma Basic Information List

Table 67. VetStem Biopharma Description and Business Overview

Table 68. VetStem Biopharma Canine Arthritis Treatment Products, Services and Solutions

Table 69. Revenue (US$ Million) in Canine Arthritis Treatment Business of VetStem Biopharma (2019-2024)

Table 70. VetStem Biopharma Recent Developments

Table 71. Dechra Pharmaceuticals Plc Basic Information List

Table 72. Dechra Pharmaceuticals Plc Description and Business Overview

Table 73. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Products, Services and Solutions

Table 74. Revenue (US$ Million) in Canine Arthritis Treatment Business of Dechra Pharmaceuticals Plc (2019-2024)

Table 75. Dechra Pharmaceuticals Plc Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Canine Arthritis Treatment Downstream Customers

Table 79. Canine Arthritis Treatment Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Canine Arthritis Treatment Product Picture

Figure 2. Global Canine Arthritis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Canine Arthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Canine Arthritis Treatment Report Years Considered

Figure 5. Global Canine Arthritis Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Canine Arthritis Treatment Revenue in 2023

Figure 7. Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Non-Steroidal Anti-Inflammatory Drugs Picture

Figure 9. Opioids Picture

Figure 10. Global Canine Arthritis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Canine Arthritis Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Veterinary Hospitals and Clinics

Figure 13. Product Picture of Drug Stores

Figure 14. Product Picture of E-commerce

Figure 15. Global Canine Arthritis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Canine Arthritis Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Canine Arthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Canine Arthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Canine Arthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Canine Arthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Canine Arthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Canine Arthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Canine Arthritis Treatment Sales Value (%), (2019-2030)

Figure 28. United States Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 34. China Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 36. China Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 46. India Canine Arthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Canine Arthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 48. India Canine Arthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 49. Canine Arthritis Treatment Industrial Chain

Figure 50. Canine Arthritis Treatment Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Arthritis Treatment Medicine for Dogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet NSAIDs Market Research Report 2025

Global Pets NSAIDs Market Research Report 2025

Global Carprofen Market Research Report 2025

Global Canine Stem Cell Therapy Market Research Report 2024

Global Pet Arthritis Market Research Report 2025

Global Stem Cell Therapy for Pets Market Research Report 2024

Global Painkillers For Dogs Market Research Report 2024

Global Companion Animal Arthritis Market Research Report 2025

Medications for Canine Atopic Dermatitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Reagent Grade Firocoxib Market Research Report 2024

Canine Atopic Dermatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Stem Cell Therapy Market Research Report 2025

Global Dog Prescription Drugs Market Research Report 2024

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Steroids for Pets Market Research Report 2025

Global Dog Joint Supplement Market Research Report 2025

Dog Flea and Tick Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dog Joint Implant Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions